Monash IVF Group (ASX:MVF) said that the incident at its Brisbane clinic, where an embryo was mistakenly implanted into the wrong patient, resulting in the birth of a child, will not have a material impact on share price, according to a response to an ASX Aware letter filed on Wednesday.
The company said in response to a letter from the ASX that the incident is an isolated incident of human error.
MVF confirmed that an internal investigation is ongoing.
Shares of the company rose 7% in recent Wednesday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。